Episode Chapters
- PPI Deprescribing14:59TIDBSI: OCP Myths17:41Paper Chase #1 | Baloxavir for Uncomplicated Flu7:16Beyond Pixar: Perfectionism, EQ, and the Middle WayFree Chapter23:19Paper Chase #2 | Procalcitonin-Guided Antibiotics in Lower Resp Tract Infection6:21Egg Freezing and Genetic Screening7:02Beyond Pixar: Self-Care and the System15:55Paper Chase #3 | Effect of Pip-Tazo vs Meropenem in Bacteremia5:58Medicolegal Risks of Low Risk Chest Pain22:45Hospitalist Corner: Preventing AKI21:39Paper Chase #4 | Managing Low-Risk PE Patients Without Hospitalization5:17Gastroesophageal Reflux Disease19:28Transient Global Amnesia (TGA)16:40Paper Chase #5 | Influence of FIT Positivity Thresholds on Cancer Detection7:55The Summary9:45
When a listener asked us about the adverse effects of proton pump inhibitors and whether (and how) we should deprescribe these drugs, Neda and Rob jumped all over it. In this segment, they’ll review the major categories of adverse effects described in the literature and figure out what it all means.
Hello, New Year! Bye Bye, PPIs? Full episode audio for MD edition 201:19 min - 94 MB - M4APC RAP January 2019 Written Summary 386 KB - PDF
Ian L., Dr - January 5, 2019 10:42 PM
If we fear interstitial nephritis then before prescribing PPI's we ought order Serum Creatinine and Uric acid and test urine for excretion of Glucose Bicarbonate Phosphate Uric acid .
These tests will become abnormal if the Tubules of the Kidney become damaged as in the Fanconi Syndrome .
Interstitial nephritis occurs early within days or weeks so test Weekly after introduction .
As for Iron the belief is ferritin is absorbed in the duodenum according to many and gastric acid is not needed for heme absorption though it is for non heme .
Dementitia seems an unproven side effect Gastrobleeds would be very much more serious .
Co-Therapy of PPI's with the Direct AntiCoagulants and Warfarin reduce Gastro Intestinal bleeding markedly and are more effective than H2 Antagonists .
Ray WA et al JAMA 2018 Dec4 ;320(21) 2221-2230 .
Christopher B. - January 8, 2019 12:57 PM
Perhaps it is coming in a future episode but I would love a "how to" segment on how exactly to deprescribe PPIs. I'm certainly not starting long-term PPI use in any new patients but seems like any new patient to my practice has already been on these for years without clear indication. I do my best to use the algorithm from Deprescribing.org (https://deprescribing.org/wp-content/uploads/2018/08/ppi-deprescribing-algorithm_2018_En.pdf) but, honestly, I've maybe had success with a handful of motivated patients and the rest are still on them.
What do others do?
Is there best practice?
How do we fit in this conversation during 15 minute OP visits where 15 other items seem to always take priority?
Neda F., MD - January 10, 2019 1:15 PM
What a great idea, Christopher. It can feel overwhelming to actually DO the thing of deprescribing PPIs. While no specific tapering method has been found to be superior to any other, a common strategy is to decrease the dose by 50% per week. For example, go from BID dosing to daily dosing one week, then cut that dose in half the next week, then move to every other day dosing the following week. And as for your last question, about all the items to discuss in a 15-minute visit... I feel your pain! So very much. We'll add this to our list of topics to cover. Thanks for writing!
Kevin H. - February 10, 2019 5:09 PM
Thanks for covering this difficult topic. It still is not clear to me from these papers as to which of these PPI-associated outcomes are linked specifically to proton pump inhibition versus acid suppression overall. Without a mechanistic understanding of risks and benefits, it becomes hard to counsel patients whose chronic symptoms are not successfully controlled with lifestyle modifications alone.